3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
3
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
12
CNS
10
Gastrointestinal
7
Head & Neck
6
Thoracic
3
Tumor-Agnostic
1
Sarcoma
1
Lymphoid
1
Genitourinary
1
Endocrine
1
Conditions
Osteosarcoma
1
Interventions
Radiotherapy
35
Doxorubicin
30
Ifosfamide
29
Cyclophosphamide
24
Vincristine
23
Filgrastim
23
Etoposide
20
Temozolomide
14
Granulocyte Colony-Stimulating Factor
14
Dactinomycin
11
Cisplatin
11
Trabectedin
10
Methotrexate
10
Gene Expression Profiling
10
Radiation
9
Imatinib Mesylate
9
Surgical Procedures, Operative
8
Polymerase Chain Reaction
8
Irinotecan
8
Specimen Handling
7
Paclitaxel
7
Chemotherapy, Adjuvant
7
Mesna
6
Immunohistochemistry
6
Gemcitabine
6
Carmustine
6
Biopsy
6
sargramostim
5
pegfilgrastim
5
etoposide phosphate
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Platinum
×
Sarcoma
×
Clear all
NCT00134030
2023-06-07
EURAMOS-1
Children's Oncology Group
Phase 3
Completed
1,334 enrolled
17 charts